HOME >> BIOLOGY >> NEWS
UNC-CH bus brings mobile lab, high-tech science focus to underserved N.C. schools

as an ongoing resource for students, teachers and their schools and districts," he said. "The project will explore how universities and schools can best collaborate to contribute to science education reform in North Carolina. The support and interest from Glaxo Wellcome and its scientists will greatly advance our exploration."

The traveling science laboratory, which was built on a BlueBird chassis customized by Ohio Bus Specialty Vehicles in Canton, Ohio, will provide students and teachers access to equipment and instruction with a minimum of movement. Equipment inside includes wireless Internet access via satellite, laptop computers donated by IBM Corp., gel electrophoresis apparatus for separating proteins and DNA, a thermocycler for polymerase chain reaction experiments and incubators. Other items include spectrophotometers for finding the quantity of protein in a solution, a special plate reader to determine the concentration of a protein and a remotely controlled camera that enables students to see a teacher's demonstration on video monitors throughout the bus.

Program activities include a cutting-edge biomolecular science curriculum and inquiry-based, hands-on experiments developed by the Boston University School of Medicine's CityLab that include modules such as "The Case of the Crown Jewels," a DNA fingerprinting exercise, or "The Mystery of the Crooked Cell," which involves determining if a hypothetical patient has sickle cell anemia.

Local business and educational leaders will be invited to participate in activities during bus stops, which are expected to span several days at each site, Bollenbacher said.

The project will tap partners working to advance science education in North Carolina, he said. For example, the involvement of LEARN North Carolina, a one-stop Web site offered free to all N.C. public school systems through UNC-CH's School of Education, should broaden awareness of the variety of excellent programs at UNC-CH and elsewhere
'"/>

Contact: Mike McFarland
mike_mcfarland@unc.edu
919-962-8593
University of North Carolina at Chapel Hill
5-Apr-2000


Page: 1 2 3 4

Related biology news :

1. UNC-CH study indicates special vaccines could prevent insulin-dependent diabetes
2. Feds give $16 million to UNC-CH scientists studying waste site problems
3. UNC-CH study offers new evidence that garlic protects against cancers
4. UNC-CH researchers to study social effects of N.C. hurricane
5. UNC-CH experiments reveal new pen can disinfect water
6. UNC-CH researchers to comb N.C. mountains for iron problem chiefly affecting Scots, Irish
7. UNC-CH biologists identify new order of marine fungi
8. UNC-CH scientists create worlds smallest pieces of ice
9. UNC-CH scientist finds smallest number of genes needed for organisms survival
10. UNC-CH scientist encourages all to watch PBS series on microbes
11. Prestigious new nutrition research center being established at UNC-CH with NIH funding

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UNC bus brings mobile lab high tech science focus underserved schools

(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/25/2015)... -- According to a new market ... Technology, Material (Optical Prism, Piezoelectric, Capacitive & Adhesives), ... & Geography - Global Forecast to 2014 - ... expected to reach $14,500.07 Million by 2020, at ... 76 market Tables and 109 Figures spread through ...
(Date:6/24/2015)... YORK , June 24, 2015 The ... rate. The major drivers for the market include growth ... number of new drug launches. Over the years, the ... increased. Between 2001 and 2010, the FDA approved 225 ... according to WIPO, Europe accounted ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
(Date:7/1/2015)... 2015   Decision Resources Group finds ... Otezla are its oral administration, alternative mechanism of ... surveyed rheumatologists. Otezla was the first oral therapy ... active psoriatic arthritis in the United ... includes conventional oral treatments including disease-modifying antirheumatic drugs ...
(Date:7/1/2015)... and BANGALORE, India , July 1, ... company that uses next generation sequencing technology to empower ... A. Storrer as chief executive officer. In his ... be responsible for all strategy, business expansion and worldwide ... has served as Strand,s chairman and CEO since its ...
(Date:7/1/2015)... 1, 2015  Axovant Sciences Ltd. (NYSE:  AXON), ... treatment of dementia, today announced that the company ... at 5:45 p.m. EDT following its presentation of ... Conference 2015 (AAIC). The event ... Dr. Lawrence Friedhoff , Chief Development Officer, ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan contest will ask ... to innovation in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will ... and a period of expert mentorship from a senior industry figure drawn from the ...
Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: